Bevacizumab, also called Avastin, is often used in treating advanced or recurrent endometrial cancer, but at what cost? This drug was originally approved by the Food and Drug Administration for treating metastatic breast cancer. This approval was later revoked due to unacceptable severe side effects and no benefit in extending survival. Yet, it is still used as an off-label drug for endometrial cancer patients. Read this post to learn more about this powerful drug, what it does and who are the most appropriate patients.
Peripheral neuropathy is one of the most common side effects of chemotherapy for uterine cancer patients. It can be very debilitating and affect the quality of life for many women. In this post I am going to discuss what this is, how you can prevent it from happening and ways to treat it if you already suffer from this. I am also going to share a supplement commonly recommended by oncologists for this problem that you should not take.
With the advent of new, advanced testing techniques, researchers have discovered 4 distinct molecular subtypes of endometrial cancer. These subtypes are now being routinely used in clinical practice and help identify patients at high risk of recurrence and guide treatment options. One of these subtypes shows a high-grade, aggressive tumor phenotype, but has an excellent prognosis and oncologists are not recommending any further treatment besides surgery for these patients. Read this post to learn what molecular subtype you fall into and what natural supplements and treatments can help.
Immunotherapy is being used more often for uterine cancer with good success. However, there are some factors that make it more successful for certain patients. Read this post to see if this may be an option for you and talk to your oncologist about it.
Are you going to be receiving chemotherapy for uterine cancer or know someone who is? Make sure to read this post. Included are some of the pros and cons of chemo and a list of questions for your oncologist to help you make informed decisions about your treatment plan.